Back to Search
Start Over
Antenatal magnesium sulfate to prevent cerebral palsy.
- Source :
-
Archives of disease in childhood. Fetal and neonatal edition [Arch Dis Child Fetal Neonatal Ed] 2022 Mar; Vol. 107 (2), pp. 225-227. Date of Electronic Publication: 2021 Jul 07. - Publication Year :
- 2022
-
Abstract
- Magnesium sulfate given to women before birth at <30 weeks' gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks' gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
Details
- Language :
- English
- ISSN :
- 1468-2052
- Volume :
- 107
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Archives of disease in childhood. Fetal and neonatal edition
- Publication Type :
- Academic Journal
- Accession number :
- 34233908
- Full Text :
- https://doi.org/10.1136/archdischild-2021-321817